A Phase 2 interventional study of Heated lidocaine and tetracaine topical patch in Shoulder Impingement Syndrome, sponsored by ZARS Pharma Inc.. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2012-03-16.
Sponsored by ZARS Pharma Inc. · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 31 studies in Shoulder Impingement Syndrome with a site in United States — 3 open to participants now, 4 under way, none of them phase 3. Shoulder Impingement Syndrome · United States.
Among the 31 studies in Shoulder Impingement Syndrome with a site in United States, this one is the 22nd largest by enrollment of the 27 interventional ones that give a count, is one of 3 that started in 2010, is one of 4 in phase 2, and was the 4th registered.
320 studies on the registry are indexed under Shoulder Impingement Syndrome; 62 are open to participants now.
Browse Shoulder Impingement Syndrome studies →3 of the 31 studies in Shoulder Impingement Syndrome with a site in United States are open now. Recruiting first, the newest first:
Lisa Griffin · Sites in United States
Ages 60+
University of Florida · Sites in United States
Ages 18–50
California State University, Long Beach · Sites in United States
Ages 18–70
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 32 Shoulder Impingement Syndrome studies recruiting now, 3 (9%) set no upper age limit and 25 (78%) stop at 75 or younger; 1 takes children under 18; 6 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
31 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 3 started in 2010.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 20 is below the median of 54 across 271 interventional studies indexed under Shoulder Impingement Syndrome.
Median enrollment 40 across the 27 interventional studies, 39 across the 4 observational. Of the 24 that completed or were terminated, 8 (33%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 31 have an industry lead sponsor. The 10 most frequent:
ZARS Pharma Inc. is the lead sponsor of 24 studies on the registry; none are open to participants now.
ZARS Pharma Inc. has 1 study filed under Shoulder Impingement Syndrome — fewer than ten, so there is no comparison to draw.
3 of the studies in Shoulder Impingement Syndrome with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06873113University of FloridaBFRT for Subacromial Pain | 2027-03-31 |
| NCT02600910The University of Texas Medical Branch, GalvestonNatural History of Shoulder Pathology in Manual Wheelchair Users | 2027-06 |
| NCT07464639California State University, Long BeachComparison of Dynamic Ultrasound Visual Feedback to Manual Feedback on Scapular Stabilizer Activation and Change in the Subacromial Space in Persons With Pain During Shoulder Elevation | 2027-10-15 |
Add all 3 to your calendar (.ics) → With an account.
Among the 31 studies in Shoulder Impingement Syndrome with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of the study is to explore the potential usefulness of a heated lidocaine 70 mg/tetracaine 70 mg topical patch for the treatment of pain associated with shoulder impingement syndrome
The purpose of this single center, 2-week open-label pilot study is to explore the potential usefulness of a heated lidocaine 70 mg and tetracaine 70 mg topical patch for the treatment of pain associated with shoulder impingement syndrome. A number of efficacy variables will be employed to evaluate their utility for assessing painful responses in this population.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Other protocol-defined inclusion/exclusion criteria may apply
Patients will be instructed to apply one heated lidocaine 70 mg and tetracaine 70 mg topical patch to the affected shoulder every 12 hours starting on the evening of Day 1 through the morning of Day 14 (morning and evening applications) and to remove the patch after 2-4 hours.
Drug: Heated lidocaine and tetracaine topical patch
Drug page: Lidocaine
Patients will be instructed to apply one heated lidocaine 70 mg and tetracaine 70 mg topical patch to the affected shoulder every 12 hours starting on the evening of Day 1 through the morning of Day 14 (morning and evening applications) and to remove the patch after 2-4 hours.
Also known as: Synera
Pain intensity
Time frame: Two weeks
Pain interference with activities (general, normal work, and sleep)
Time frame: Two weeks
The record gives a start of Mar 2010, a primary completion of Aug 2010 and a completion of Sep 2010. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Lidocaine
Shoulder Impingement Syndrome →